Stealth BioTherapeutics (Stealth BioTherapeutics) Ending Cash Position : $0.00 Mil (As of Mar. 2022)

View and export this data going back to 2019. Start your Free Trial

What is Stealth BioTherapeutics Ending Cash Position?

Stealth BioTherapeutics's Ending Cash Position for the quarter that ended in Mar. 2022 was $0.00 Mil.

Stealth BioTherapeutics's annual Ending Cash Position declined from Dec. 2019 ($50.77 Mil) to Dec. 2020 ($32.79 Mil) but then increased from Dec. 2020 ($32.79 Mil) to Dec. 2021 ($47.14 Mil).

Stealth BioTherapeutics Ending Cash Position Historical Data

The historical data trend for Stealth BioTherapeutics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stealth BioTherapeutics Ending Cash Position Chart

Stealth BioTherapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Ending Cash Position

Get a 7-Day Free Trial

4.12

10.86

50.77

32.79

47.14

Stealth BioTherapeutics Quarterly Data
	Dec16	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22
Ending Cash Position	Get a 7-Day Free Trial															-	-	-	-	-

Stealth BioTherapeutics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Stealth BioTherapeutics's Ending Cash Position for the fiscal year that ended in Dec. 2021 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	32.787	+	14.348
	=	47.14

Stealth BioTherapeutics's Ending Cash Position for the quarter that ended in Mar. 2022 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0	+	0
	=	0.00

Stealth BioTherapeutics Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Stealth BioTherapeutics's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Stealth BioTherapeutics (Stealth BioTherapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stealth BioTherapeutics Corp (NAS:MITO) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

c/o Intertrust Corporate Services (Cayman) Limited, One Nexus way, Camana Bay, Grand Cayman, CYM, KY1-9005

Website

https://www.stealthbt.com

Stealth BioTherapeutics Corp is a clinical-stage biotechnology company. It is focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction.